Helsinn and Fosun Pharma sign exclusive license and distribu

Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR | Comunicados | Edición USA

Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR | Comunicados | Edición USA

efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Lugano , Ticino , Switzerland , Shanghai , Hong Kong , Macau , Swiss , Barney Liu , Paola Bonvicini , Fosun Pharmasign , Riccardo Braglia , Wu Yifang , Fosun Pharma , Ireland Helsinn Birex Pharmaceuticals Ltd , Helsinn Group Vice , Sinopharm Co Ltd , Us Helsinn Therapeutics Inc , Shanghai Fosun Pharmaceutical Group Co Ltd , Shanghai Fosun Pharmaceutical Industrial Development Co , Helsinn Group , China Helsinn Pharmaceuticals Beijing Co Ltd , China National Medical Products Administration , Group Head Of Communication , Swiss Biopharmaceutical Group , Helsinn Group Media Contact , Helsinn Pharmaceuticals Beijing Co , Mainland China , Fosun Pharmaceutical , Shanghai Fosun Pharmaceutical , Post Operative Nausea , Malignancy Associated Weight Loss , Helsinn Pharmaceuticals Beijing , Helsinn Group Vice Chairman , Hydrochloride Soft Capsules , Helsinn Therapeutics , Helsinn Pharmaceuticals , Helsinn Birex Pharmaceuticals Ltd , Group Media Contact ,